CBR1 and cancer: Suppression of HIF-1α-induced CBR1 by resveratrol (10 μM) increased the sensitivity of hypoxic breast cancer cells to doxorubicin, making the hypoxic cancer cells sensitive to doxorubicin as shown in normoxic cancer cells [39].